Infigratinib low dose therapy is an effective strategy to treat hypochondroplasia. [PDF]
Demuynck B +9 more
europepmc +1 more source
Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs. [PDF]
Kamrul-Hasan ABM +6 more
europepmc +1 more source
Evidence-based classification of genes implicated in skeletal disorders using the ClinGen curation framework. [PDF]
Webb RF +27 more
europepmc +1 more source
O03: Vosoritide increases growth velocity in hypochondroplasia: Phase 2 trial results
Andrew Dauber +9 more
doaj +1 more source
Application of trio-based whole-exome sequencing in fetal ultrasound anomalies: a single-center retrospective study of 454 cases. [PDF]
Yu D +8 more
europepmc +1 more source
A phase II basket trial of vosoritide in children with RASopathies, ACAN, and NPR2 deficiency.
Dauber A +7 more
europepmc +1 more source
Acanthosis Nigricans in Hypochondroplasia Due to <i>FGFR3</i> Mutation. [PDF]
Junkin JR, Ramirez V, Quintos JB.
europepmc +1 more source
Brachydactyly Type A1 Caused by an <i>IHH</i> Variant in a Patient with Disproportionate Short Stature: A Case Report. [PDF]
García de Pablo I +4 more
europepmc +1 more source

